345 related articles for article (PubMed ID: 30959074)
1. Antiviral activity of pinocembrin against Zika virus replication.
Lee JL; Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Jul; 167():13-24. PubMed ID: 30959074
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
Adcock RS; Chu YK; Golden JE; Chung DH
Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus.
Pitts JD; Li PC; de Wispelaere M; Yang PL
Antiviral Res; 2017 Nov; 147():124-130. PubMed ID: 29051080
[TBL] [Abstract][Full Text] [Related]
5. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking
Riva L; Goellner S; Biering SB; Huang CT; Rubanov AN; Haselmann U; Warnes CM; De Jesus PD; Martin-Sancho L; Terskikh AV; Harris E; Pinkerton AB; Bartenschlager R; Chanda SK
J Virol; 2021 Oct; 95(22):e0099621. PubMed ID: 34468177
[TBL] [Abstract][Full Text] [Related]
6. Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms.
Lai ZZ; Ho YJ; Lu JW
Molecules; 2020 Sep; 25(18):. PubMed ID: 32906689
[TBL] [Abstract][Full Text] [Related]
7. Cinnamic acid inhibits Zika virus by inhibiting RdRp activity.
Chen Y; Li Z; Pan P; Lao Z; Xu J; Li Z; Zhan S; Liu X; Wu Y; Wang W; Li G
Antiviral Res; 2021 Aug; 192():105117. PubMed ID: 34174248
[TBL] [Abstract][Full Text] [Related]
8. The citrus flavonoid naringenin impairs the in vitro infection of human cells by Zika virus.
Cataneo AHD; Kuczera D; Koishi AC; Zanluca C; Silveira GF; Arruda TB; Suzukawa AA; Bortot LO; Dias-Baruffi M; Verri WA; Robert AW; Stimamiglio MA; Duarte Dos Santos CN; Wowk PF; Bordignon J
Sci Rep; 2019 Nov; 9(1):16348. PubMed ID: 31705028
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro.
Baltina LA; Lai HC; Liu YC; Huang SH; Hour MJ; Baltina LA; Nugumanov TR; Borisevich SS; Khalilov LM; Petrova SF; Khursan SL; Lin CW
Bioorg Med Chem; 2021 Jul; 41():116204. PubMed ID: 34022526
[TBL] [Abstract][Full Text] [Related]
10. Baicalein and baicalin as Zika virus inhibitors.
Oo A; Teoh BT; Sam SS; Bakar SA; Zandi K
Arch Virol; 2019 Feb; 164(2):585-593. PubMed ID: 30392049
[TBL] [Abstract][Full Text] [Related]
11. Identification of Inhibitors of ZIKV Replication.
Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro.
Vicenti I; Boccuto A; Giannini A; Dragoni F; Saladini F; Zazzi M
Virus Res; 2018 Jan; 244():64-70. PubMed ID: 29113824
[TBL] [Abstract][Full Text] [Related]
13. Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles.
Albulescu IC; Kovacikova K; Tas A; Snijder EJ; van Hemert MJ
Antiviral Res; 2017 Jul; 143():230-236. PubMed ID: 28461070
[TBL] [Abstract][Full Text] [Related]
14. Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.
Kamiyama N; Soma R; Hidano S; Watanabe K; Umekita H; Fukuda C; Noguchi K; Gendo Y; Ozaki T; Sonoda A; Sachi N; Runtuwene LR; Miura Y; Matsubara E; Tajima S; Takasaki T; Eshita Y; Kobayashi T
Antiviral Res; 2017 Oct; 146():1-11. PubMed ID: 28818572
[TBL] [Abstract][Full Text] [Related]
15. Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models.
Kim JA; Seong RK; Kumar M; Shin OS
Viruses; 2018 Feb; 10(2):. PubMed ID: 29425176
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol affects Zika virus replication in vitro.
Mohd A; Zainal N; Tan KK; AbuBakar S
Sci Rep; 2019 Oct; 9(1):14336. PubMed ID: 31586088
[TBL] [Abstract][Full Text] [Related]
17. A synthetic derivative of houttuynoid B prevents cell entry of Zika virus.
Basic M; Elgner F; Bender D; Sabino C; Herrlein ML; Roth H; Glitscher M; Fath A; Kerl T; Schmalz HG; Hildt E
Antiviral Res; 2019 Dec; 172():104644. PubMed ID: 31697958
[TBL] [Abstract][Full Text] [Related]
18. Identification of Ascomycin against Zika virus infection through screening of natural product library.
Zhou L; Zhou J; Chen T; Chi X; Liu X; Pan S; Chen W; Wu T; Lin T; Zhang X; Li YP; Yang W
Antiviral Res; 2021 Dec; 196():105210. PubMed ID: 34801589
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput Screening Identifies Mixed-Lineage Kinase 3 as a Key Host Regulatory Factor in Zika Virus Infection.
Xu H; Cheng M; Chi X; Liu X; Zhou J; Lin T; Yang W
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270223
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antiviral activity of Sofosbuvir and type-I interferons (α and β) against Zika virus.
Snyder B; Goebel S; Koide F; Ptak R; Kalkeri R
J Med Virol; 2018 Jan; 90(1):8-12. PubMed ID: 28851097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
